The product referred to as "Clinimix e 2 75/25 sulfite free w/ elect in dextrose 25% w/ calcium in plastic container" is a pharmaceutical product designed for intravenous administration. It is a sterile, non-pyrogenic solution containing amino acids, electrolytes, and dextrose, formulated without sulfite preservatives [1]. The "e" in its designation likely refers to its "elevated" amino acid concentration, and the "2 75/25" indicates the specific ratio of amino acids and dextrose [1][2].
What is Clinimix e 2 75/25 used for?
Clinimix e 2 75/25 is indicated for use in parenteral nutrition for patients requiring nutritional support when oral or enteral intake is not possible or sufficient. It provides carbohydrates, amino acids, and electrolytes to meet the metabolic needs of patients [1]. The formulation is designed for patients who may be sensitive to sulfites, which are commonly used as preservatives in some intravenous solutions [1][3].
How is Clinimix e 2 75/25 administered?
This product is intended for intravenous infusion. It is typically administered through a central venous catheter. The specific dosage and rate of administration are determined by the patient's individual nutritional requirements, body weight, and clinical status [1].
What are the components of Clinimix e 2 75/25?
The solution contains specific amounts of amino acids, dextrose, and electrolytes. The amino acid profile is designed to support protein synthesis and other metabolic functions. Dextrose provides a source of calories. The electrolytes included are essential for maintaining fluid and electrolyte balance [1]. The absence of sulfites is a key feature of this particular formulation [1][3].
Where can I find more information about drug formulations and patents?
Information regarding pharmaceutical formulations, including ingredients and specific product details, can often be found through drug databases and regulatory filings. For details on drug patents and exclusivity periods, resources like DrugPatentWatch.com provide comprehensive data that can help track the patent landscape for various medications [4].